US equities
|
NVDA
$125.53
▼-14.01%
ANT
$88.91
▼-8.50%
MU
$594.51
▼-13.89%
AMD
$424.39
▼-13.25%
AAPL
$342.56
▼-1.90%
MSFT
$484.52
▼-2.77%
AMZN
$246.82
▼-4.10%
AVGO
$304.41
▼-12.19%
NVDA
$125.53
▼-14.01%
ANT
$88.91
▼-8.50%
MU
$594.51
▼-13.89%
AMD
$424.39
▼-13.25%
AAPL
$342.56
▼-1.90%
MSFT
$484.52
▼-2.77%
AMZN
$246.82
▼-4.10%
AVGO
$304.41
▼-12.19%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Reunion Neuroscience Inc/
Recent news which mentions Reunion Neuroscience Inc/
Hope For Postpartum Depression: This Company To Launch Clinical Trial On Next-Gen Psychedelic
September 18, 2023
Tickers
MSSTF
Tags
Global
Next/Generation Psychedelics
Market News
From
Benzinga
Former Field Trip Health, Now Reunion Neuroscience: Q1 2023 Financial Results & Corporate Reorganization
August 16, 2022
Tags
Benzinga
Earnings
Global
From
Benzinga
Field Trip's Phase I Clinical Study Of Psilocybin Analog FT-104 Begins Dosing In Australia
July 21, 2022
Tags
Joseph del Moral
News
Royal Adelaide Hospital
From
Benzinga
Field Trip Health To Divide Into Two Separate Public Companies
April 29, 2022
Tickers
FTRP
Tags
Field Trip Discovery
Markets
Reunion Neuroscience Inc/
From
Benzinga